List of Tables
Table 1. Global Nasal Spray Live Attenuated Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Nasal Spray Live Attenuated Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Nasal Spray Live Attenuated Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nasal Spray Live Attenuated Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nasal Spray Live Attenuated Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2021–2026
Table 18. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2027–2032
Table 20. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
Table 27. North America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
Table 28. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
Table 32. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
Table 33. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
Table 42. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
Table 43. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2021–2026)
Table 51. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2027–2032)
Table 52. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2021–2026)
Table 61. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2027–2032)
Table 62. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. AstraZeneca Nasal Spray Live Attenuated Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Sanofi Nasal Spray Live Attenuated Vaccine Product
Table 79. Sanofi Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. CSL Nasal Spray Live Attenuated Vaccine Product
Table 84. CSL Recent Developments/Updates
Table 85. BioDiem Company Information
Table 86. BioDiem Description and Business Overview
Table 87. BioDiem Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. BioDiem Nasal Spray Live Attenuated Vaccine Product
Table 89. BioDiem Recent Developments/Updates
Table 90. SEQIRUS, INC. Company Information
Table 91. SEQIRUS, INC. Description and Business Overview
Table 92. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product
Table 94. SEQIRUS, INC. Recent Developments/Updates
Table 95. Changchun BCHT Biotechnology Co. Company Information
Table 96. Changchun BCHT Biotechnology Co. Description and Business Overview
Table 97. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product
Table 99. Changchun BCHT Biotechnology Co. Recent Developments/Updates
Table 100. Serum Institute Company Information
Table 101. Serum Institute Description and Business Overview
Table 102. Serum Institute Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Serum Institute Nasal Spray Live Attenuated Vaccine Product
Table 104. Serum Institute Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Nasal Spray Live Attenuated Vaccine Distributors List
Table 108. Nasal Spray Live Attenuated Vaccine Customers List
Table 109. Nasal Spray Live Attenuated Vaccine Market Trends
Table 110. Nasal Spray Live Attenuated Vaccine Market Drivers
Table 111. Nasal Spray Live Attenuated Vaccine Market Challenges
Table 112. Nasal Spray Live Attenuated Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nasal Spray Live Attenuated Vaccine
Figure 2. Global Nasal Spray Live Attenuated Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Nasal Spray Live Attenuated Vaccine Market Share by Type: 2025 & 2032
Figure 4. Trivalent Nasal Spray Live Attenuated Vaccine Product Picture
Figure 5. Quadrivalent Nasal Spray Live Attenuated Vaccine Product Picture
Figure 6. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Nasal Spray Live Attenuated Vaccine Market Share by Application: 2025 & 2032
Figure 8. Hospitals & Clinics
Figure 9. Public Health Organizations
Figure 10. Research Organizations
Figure 11. Others
Figure 12. Global Nasal Spray Live Attenuated Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Nasal Spray Live Attenuated Vaccine Market Size (US$ Million), 2021–2032
Figure 14. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose), 2021–2032
Figure 15. Global Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose), 2021–2032
Figure 16. Nasal Spray Live Attenuated Vaccine Report Years Considered
Figure 17. Nasal Spray Live Attenuated Vaccine Sales Share by Manufacturers in 2025
Figure 18. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Nasal Spray Live Attenuated Vaccine Players: Market Share by Revenue in Nasal Spray Live Attenuated Vaccine in 2025
Figure 20. Nasal Spray Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
Figure 23. North America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
Figure 24. United States Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
Figure 27. Europe Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2021–2032)
Figure 35. China Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Type (2021–2032)
Figure 55. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Application (2021–2032)
Figure 58. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 59. Nasal Spray Live Attenuated Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed